Evidence map›Paper›PMID 35900783›Full record

GuidelineEndocrine-related cancer2022

Paediatric differentiated thyroid carcinoma: a UK National Clinical Practice Consensus Guideline.

Sasha R Howard, Sarah Freeston, Barney Harrison, Louise Izatt, Sonali Natu, Kate Newbold, Sabine Pomplun, Helen A Spoudeas, Sophie Wilne, Tom R Kurzawinski and 1 more

Abstract readPractice Guideline
PubMed Full text at PMC Publisher
In one paragraph

Guideline in Endocrine-related cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sasha R HowardCentre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, UK.ORCID 0000-0002-6698-903X
Sarah FreestonWhipps Cross Hospital, Barts Health NHS Trust, London, UK.
Barney HarrisonRetired Endocrine Surgeon, Sheffield, UK.
Louise IzattDepartment of Clinical and Cancer Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Sonali NatuDepartment of Pathology, University Hospital of North Tees and Hartlepool NHS Foundation Trust, Stockton-on-Tees, UK.
Kate NewboldDepartment of Clinical Oncology, Royal Marsden Hospital Foundation Trust, London, UK.
Sabine PomplunDepartment of Pathology, University College London Hospital NHS Foundation Trust, London, UK.
Helen A SpoudeasDepartment of Paediatric Endocrinology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Sophie WilneDepartment of Paediatric Oncology, Nottingham University Hospital's NHS Trust, Nottingham, UK.
Tom R KurzawinskiDepartment of Endocrine Surgery, University College London Hospitals NHS Foundation Trust, London, UK.ORCID 0000-0002-4910-2601
Mark N GazeDepartment of Clinical Oncology, University College London Hospitals NHS Foundation Trust, London, UK.

Funding

Cancer Research UK 28990Cancer Research UK C7893/A28990Department of Health
6 · The paper itself

Abstract

This guideline is written as a reference document for clinicians presented with the challenge of managing paediatric patients with differentiated thyroid carcinoma up to the age of 19 years. Care of paediatric patients with differentiated thyroid carcinoma differs in key aspects from that of adults, and there have been several recent developments in the care pathways for this condition; this guideline has sought to identify and attend to these areas. It addresses the presentation, clinical assessment, diagnosis, management (both surgical and medical), genetic counselling, follow-up and prognosis of affected patients. The guideline development group formed of a multi-disciplinary panel of sub-speciality experts carried out a systematic primary literature review and Delphi Consensus exercise. The guideline was developed in accordance with The Appraisal of Guidelines Research and Evaluation Instrument II criteria, with input from stakeholders including charities and patient groups. Based on scientific evidence and expert opinion, 58 recommendations have been collected to produce a clear, pragmatic set of management guidelines. It is intended as an evidence base for future optimal management and to improve the quality of clinical care of paediatric patients with differentiated thyroid carcinoma.

Indexed as

Thyroid NeoplasmsAdultChildHumansPrognosisUnited KingdomYoung Adultdifferentiated thyroid cancerfollicular thyroid cancerpaediatric cancerpapillary thyroid cancerthyroid

Identifiers

PMID35900783
PMCPMC9513650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.